- Home
- RML vs ELAN Comparison
RML vs ELAN Comparison
Compare RML & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RML | ELAN |
|---|---|---|
| Founded | 2017 | 1954 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 12.2B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | RML | ELAN |
|---|---|---|
| Price | $5.20 | $22.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 14.1K | ★ 4.3M |
| Earning Date | 12-13-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.66 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | ★ N/A | $104.30 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $5.25 | $19.40 |
| 52 Week High | $6.56 | $27.98 |
Technical Indicators
Market Signals| Indicator | RML | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 19.07 | 46.54 |
| Support Level | N/A | $21.73 |
| Resistance Level | $5.65 | $25.21 |
| Average True Range (ATR) | 0.25 | 0.66 |
| MACD | -0.07 | 0.10 |
| Stochastic Oscillator | 0.00 | 54.11 |
Price Performance
Historical ComparisonAbout RML Resolution Minerals Ltd American Depositary Shares
Resolution Minerals Ltd is a mineral exploration company engaged in the acquisition, exploration, and development of precious and battery metals, such as antimony, gold, copper, and uranium. It is focused on critical defense minerals, together with gold and silver, to deliver a solution for domestic antimony supply to the U.S defense industry. The Horse Heaven antimony-tungsten-gold project in Idaho is Resolution's flagship project, adjoining Perpetua's Stibnite antimony-gold project.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.